Immune-active microenvironment in SCCOHT: Rationale for therapy with immune checkpoint blockade.

被引：0
|
作者：
Van Oudenhove, Elke [1 ]
Jelinic, Petar [1 ]
Ricca, Jacob [2 ]
Narciso, Olvera [1 ]
Merghoub, Taha
Levine, Douglas A. [1 ]
Zamarin, Dmitriy [2 ]
机构：
[1] NYU, Sch Med, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
CLINICAL CANCER RESEARCH | 2018年 / 24卷 / 15期
关键词：
D O I：
10.1158/1557-3265.OVCA17-B26
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B26
引用
收藏
页码：95 / 95
页数：1
相关论文
共 50 条
  • [31] The role of neoantigen in immune checkpoint blockade therapy
    Ming Yi
    Shuang Qin
    Weiheng Zhao
    Shengnan Yu
    Qian Chu
    Kongming Wu
    Experimental Hematology & Oncology, 7
  • [32] Immune checkpoint blockade therapy in cancer and beyond
    Minato, Nagahiro
    CYTOKINE, 2017, 100 : 23 - 23
  • [33] Immune-Checkpoint Blockade Therapy in Lymphoma
    Kuzume, Ayumi
    Chi, SungGi
    Yamauchi, Nobuhiko
    Minami, Yosuke
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (15) : 1 - 15
  • [34] Preclinical rationale and clinical efficacy of antiangiogenic therapy and immune checkpoint blockade combination therapy in urogenital tumors
    Zhu, Ning
    Weng, Shanshan
    Wang, Juan
    Chen, Jiaqi
    Yu, Linzhen
    Fang, Xuefeng
    Yuan, Ying
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (12) : 3021 - 3036
  • [35] Preclinical rationale and clinical efficacy of antiangiogenic therapy and immune checkpoint blockade combination therapy in urogenital tumors
    Ning Zhu
    Shanshan Weng
    Juan Wang
    Jiaqi Chen
    Linzhen Yu
    Xuefeng Fang
    Ying Yuan
    Journal of Cancer Research and Clinical Oncology, 2019, 145 : 3021 - 3036
  • [36] Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy
    Xiao, Yuling
    Chen, Jiang
    Zhou, Hui
    Zeng, Xiaodong
    Ruan, Zhiping
    Pu, Zhangya
    Jiang, Xingya
    Matsui, Aya
    Zhu, Lingling
    Amoozgar, Zohreh
    Chen, Dean Shuailin
    Han, Xiangfei
    Duda, Dan G.
    Shi, Jinjun
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [37] Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy
    Yuling Xiao
    Jiang Chen
    Hui Zhou
    Xiaodong Zeng
    Zhiping Ruan
    Zhangya Pu
    Xingya Jiang
    Aya Matsui
    Lingling Zhu
    Zohreh Amoozgar
    Dean Shuailin Chen
    Xiangfei Han
    Dan G. Duda
    Jinjun Shi
    Nature Communications, 13
  • [38] Fluorescence imaging of tumor immune contexture in immune checkpoint blockade therapy
    Pan, Xiao
    Gao, Antian
    Lin, Zitong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 106
  • [39] Integrative tumor and immune cell multi-omic analyses to predict melanoma response to immune checkpoint blockade.
    Anagnostou, Valsamo
    Bruhm, Daniel C.
    Niknafs, Noushin
    White, James R.
    Sidhom, John-William
    Stein, Julie E.
    Tsai, Hua-Ling
    Wang, Hao
    Belcaid, Zineb
    Murray, Joseph Christopher
    Ross-Macdonald, Petra B.
    Wind-Rotolo, Megan
    Baras, Alexander S.
    Taube, Janis M.
    Scharpf, Robert B.
    Grasso, Catherine
    Ribas, Antoni
    Pardoll, Drew M.
    Topalian, Suzanne Louise
    Velculescu, Victor E.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [40] Antibody mediated blockade of phosphatidylserine improves immune checkpoint blockade by repolarizing immune suppressive mechanisms of the tumor microenvironment
    Hutchins, J.
    ANNALS OF ONCOLOGY, 2016, 27
12345